CN108034419A - A kind of water solubility full-inorganic perovskite quantum dot and preparation method thereof - Google Patents
A kind of water solubility full-inorganic perovskite quantum dot and preparation method thereof Download PDFInfo
- Publication number
- CN108034419A CN108034419A CN201711307716.6A CN201711307716A CN108034419A CN 108034419 A CN108034419 A CN 108034419A CN 201711307716 A CN201711307716 A CN 201711307716A CN 108034419 A CN108034419 A CN 108034419A
- Authority
- CN
- China
- Prior art keywords
- perovskite quantum
- inorganic perovskite
- quantum dot
- water
- full
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/66—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing germanium, tin or lead
- C09K11/664—Halogenides
- C09K11/665—Halogenides with alkali or alkaline earth metals
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Manufacturing & Machinery (AREA)
- Luminescent Compositions (AREA)
Abstract
本发明公开一种水溶性全无机钙钛矿量子点及其制备方法,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点,其外层为双亲性磷脂,内外层之间通过亲水和疏水相互作用相连接,其制备方法如下:1)制备全无机钙钛矿量子点甲苯溶液,2)将全无机钙钛矿量子点甲苯溶液与双亲性磷脂氯仿溶液混合均匀,去除有机溶剂后溶解于超纯水中,得到水溶性全无机钙钛矿量子点。本发明利用生物相容性的磷脂,将油溶性全无机钙钛矿量子点分散在水中,并实现了全无机钙钛矿量子点在水中10天以上的荧光发射,克服了由于钙钛矿量子点在水中容易水解引起的生物成像限制。
The invention discloses a water-soluble all-inorganic perovskite quantum dot and a preparation method thereof. The water-soluble all-inorganic perovskite quantum dot has a micellar structure, and its inner layer is an all-inorganic perovskite quantum dot. The outer layer is an amphiphilic phospholipid, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions. The preparation method is as follows: 1) preparing an all-inorganic perovskite quantum dot toluene solution, 2) adding an all-inorganic perovskite quantum dot toluene The solution is uniformly mixed with the amphiphilic phospholipid chloroform solution, and dissolved in ultrapure water after removing the organic solvent to obtain water-soluble all-inorganic perovskite quantum dots. The invention utilizes biocompatible phospholipids to disperse oil-soluble all-inorganic perovskite quantum dots in water, and realizes the fluorescence emission of all-inorganic perovskite quantum dots in water for more than 10 days, and overcomes the problem caused by perovskite quantum dots. Bioimaging limitations caused by easy hydrolysis of dots in water.
Description
技术领域technical field
本发明涉及一种水溶性全无机钙钛矿量子点及其制备方法,属于纳米材料学和荧光分析领域。The invention relates to a water-soluble all-inorganic perovskite quantum dot and a preparation method thereof, belonging to the fields of nanomaterials and fluorescence analysis.
背景技术Background technique
量子点(quantum dots,QDs)也称为半导体纳米晶体(semiconductornanocrystal),是指在三维空间上达到一定临界尺寸(激子波尔半径)而具有量子限域效应的半导体材料。作为一种新型的无机荧光探针,量子点具有许多独特的性质,能有效地克服有机荧光染料和荧光蛋白的一些致命弱点,主要表现为:(1)激发光谱宽且连续分布;(2)发射光谱窄,通常半高宽为25~35nm,且对称分布;(3)发射谱在400nm~1350nm范围内可调;(4)荧光量子效率较高。相比于传统的荧光染料随着材料的不同,需要多种激发光激发且发射光谱宽、重叠现象严重等特点,量子点可以实现一种激发波长下的多波长发射,并且发射谱的重叠现象不明显,使其具有多色标记和检测多组分生物样品的潜能。Quantum dots (quantum dots, QDs), also known as semiconductor nanocrystals, refer to semiconductor materials that reach a certain critical size (exciton Bohr radius) in three-dimensional space and have quantum confinement effects. As a new type of inorganic fluorescent probe, quantum dots have many unique properties, which can effectively overcome some fatal weaknesses of organic fluorescent dyes and fluorescent proteins, mainly as follows: (1) wide excitation spectrum and continuous distribution; (2) The emission spectrum is narrow, usually the full width at half maximum is 25-35nm, and the distribution is symmetrical; (3) the emission spectrum is adjustable within the range of 400nm-1350nm; (4) the fluorescence quantum efficiency is relatively high. Compared with traditional fluorescent dyes, depending on the material, a variety of excitation lights are required to be excited, and the emission spectrum is wide and the overlap phenomenon is serious. Quantum dots can realize multi-wavelength emission at an excitation wavelength, and the emission spectrum overlaps. Inconspicuous, giving it potential for multicolor labeling and detection of multicomponent biological samples.
全无机钙钛矿量子点作为一种半导体材料,具有合成简单、发射峰较窄(半高宽为12~42nm)、荧光量子效率高(最高可达90%)、发光峰位可调(调控卤素元素的种类和比例、调控量子点合成温度从而调节量子点的粒径尺寸)等特点,其拥有巨大的生物成像优势,但是水稳定性不好限制了它在生物上的应用,因此,亟需一种水溶性全无机钙钛矿量子点的制备方法以解决上述问题。As a semiconductor material, all-inorganic perovskite quantum dots have the advantages of simple synthesis, narrow emission peak (12-42nm half-maximum width), high fluorescence quantum efficiency (up to 90%), and adjustable luminescence peak position (controlling The types and proportions of halogen elements, and the adjustment of the synthesis temperature of quantum dots to adjust the particle size of quantum dots) and other characteristics, it has a huge advantage in biological imaging, but the poor water stability limits its application in biology, therefore, it is urgent A method for preparing water-soluble all-inorganic perovskite quantum dots is needed to solve the above problems.
磷脂(phospholipid),是生物膜的组成成分之一,具有亲水性头部和疏水性尾部,可以很容易的形成脂质体、胶束等结构,用于携带各种亲水的、疏水的和两亲的物质,磷脂分子包裹在全无机钙钛矿量子点的表面能有效地将油溶性全无机钙钛矿量子点分散在水中、阻止全无机钙钛矿量子点的水解,提高其稳定性和生物相容性、降低其生物毒性。Phospholipid, one of the components of biological membranes, has a hydrophilic head and a hydrophobic tail, which can easily form structures such as liposomes and micelles, and is used to carry various hydrophilic and hydrophobic And amphiphilic substances, phospholipid molecules wrapped on the surface of all-inorganic perovskite quantum dots can effectively disperse oil-soluble all-inorganic perovskite quantum dots in water, prevent the hydrolysis of all-inorganic perovskite quantum dots, and improve its stability and biocompatibility, reducing its biotoxicity.
发明内容Contents of the invention
技术问题:本发明的目的是提供一种水溶性全无机钙钛矿量子点及其制备方法,提高全无机钙钛矿量子点在水中的稳定性,实现水溶性的全无机钙钛矿量子点,且该制备方法操作简单、可重复性好、生物相容性高。Technical problem: The purpose of the present invention is to provide a water-soluble all-inorganic perovskite quantum dot and its preparation method, improve the stability of all-inorganic perovskite quantum dots in water, and realize water-soluble all-inorganic perovskite quantum dots , and the preparation method is simple to operate, good in repeatability and high in biocompatibility.
技术内容:本发明提供了一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbX3或全无机钙钛矿量子点CsPb(BrnA1-n)3,X表示Cl、Br或I中的一种,A表示Cl或I中的一种,0<n<1,其外层为双亲性磷脂,内外层之间通过亲水和疏水相互作用相连接。Technical content: The present invention provides a water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot has a micellar structure, and its inner layer is an all-inorganic perovskite quantum dot CsPbX 3 Or all inorganic perovskite quantum dots CsPb(Br n A 1-n ) 3 , X represents one of Cl, Br or I, A represents one of Cl or I, 0<n<1, the outer layer It is an amphiphilic phospholipid, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions.
其中:in:
所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbX3和油溶性纳米粒子或全无机钙钛矿量子点CsPb(BrnA1-n)3和油溶性纳米粒子,X表示Cl、Br或I中的一种,A表示Cl或I中的一种,0<n<1,其外层为双亲性磷脂,内外层之间通过亲水和疏水相互作用相连接。The water-soluble all-inorganic perovskite quantum dot is a micellar structure, and its inner layer is all-inorganic perovskite quantum dot CsPbX 3 and oil-soluble nanoparticles or all-inorganic perovskite quantum dot CsPb(Br n A 1 -n ) 3 and oil-soluble nanoparticles, X represents one of Cl, Br or I, A represents one of Cl or I, 0<n<1, the outer layer is amphiphilic phospholipid, and the inner and outer layers Linked by hydrophilic and hydrophobic interactions.
所述的双亲性磷脂为二棕榈酰磷脂酰胆碱、大豆磷脂或者二硬脂酰基磷脂酰胆碱中的一种。The amphipathic phospholipid is one of dipalmitoylphosphatidylcholine, soybean lecithin or distearoylphosphatidylcholine.
所述的全无机钙钛矿量子点CsPbX3或全无机钙钛矿量子点CsPb(BrnA1-n)3与双亲性磷脂的重量混合比例为1~1.35:54。The weight mixing ratio of the all-inorganic perovskite quantum dot CsPbX 3 or the all-inorganic perovskite quantum dot CsPb(Br n A 1-n ) 3 to the amphiphilic phospholipid is 1-1.35:54.
所述的全无机钙钛矿量子点CsPbX3或全无机钙钛矿量子点CsPb(BrnA1-n)3与油溶性纳米粒子、双亲性磷脂三者的重量混合比例为1~1.35:1~1.35:54。The weight mixing ratio of the all-inorganic perovskite quantum dots CsPbX 3 or all-inorganic perovskite quantum dots CsPb(Br n A 1-n ) 3 with oil-soluble nanoparticles and amphiphilic phospholipids is 1 to 1.35: 1~1.35:54.
本发明还提供了一种水溶性全无机钙钛矿量子点的制备方法,该方法包括以下步骤:The present invention also provides a method for preparing water-soluble all-inorganic perovskite quantum dots, the method comprising the following steps:
1)全无机钙钛矿量子点CsPbX3或全无机钙钛矿量子点CsPb(BrnA1-n)3的制备:按分子式CsPbX3中各元素的摩尔比将PbX2粉末和CsX粉末溶解在二甲基亚砜中得到混合溶液Ⅰ,或者按分子式CsPb(BrnA1-n)3中各元素的摩尔比将PbBr2粉末、PbA2粉末、CsBr粉末和CsA粉末溶解在二甲基亚砜中得到混合溶液Ⅱ,之后向混合溶液Ⅰ或混合溶液Ⅱ中加入油酸和油胺,超声至澄清得到前驱体溶液,之后将前驱体溶液加入甲苯中,得到全无机钙钛矿量子点CsPbX3的甲苯溶液或全无机钙钛矿量子点CsPb(BrnA1-n)3的甲苯溶液;1) Preparation of all-inorganic perovskite quantum dots CsPbX 3 or all-inorganic perovskite quantum dots CsPb(Br n A 1-n ) 3 : Dissolve PbX 2 powder and CsX powder according to the molar ratio of each element in the molecular formula CsPbX 3 Mix solution I in dimethyl sulfoxide, or dissolve PbBr 2 powder, PbA 2 powder, CsBr powder and CsA powder in dimethyl sulfoxide according to the molar ratio of each element in the molecular formula CsPb(Br n A 1-n ) Mixed solution II was obtained in sulfoxide, and then oleic acid and oleylamine were added to mixed solution I or mixed solution II, and the precursor solution was obtained by ultrasonication until clarified, and then the precursor solution was added to toluene to obtain all-inorganic perovskite quantum dots Toluene solution of CsPbX 3 or all-inorganic perovskite quantum dot CsPb(Br n A 1-n ) 3 toluene solution;
2)水溶性全无机钙钛矿量子点的制备:按比例将全无机钙钛矿量子点CsPbX3的甲苯溶液或全无机钙钛矿量子点CsPb(BrnA1-n)3的甲苯溶液与双亲性磷脂氯仿溶液、油溶性纳米粒子氯仿溶液混合均匀后,去除有机溶剂形成均匀薄膜,之后将薄膜溶解于超纯水中,得到水溶性全无机钙钛矿量子点。2) Preparation of water-soluble all-inorganic perovskite quantum dots: proportionally mix the toluene solution of all-inorganic perovskite quantum dots CsPbX 3 or the toluene solution of all-inorganic perovskite quantum dots CsPb(Br n A 1-n ) 3 After mixing evenly with amphiphilic phospholipid chloroform solution and oil-soluble nanoparticle chloroform solution, the organic solvent is removed to form a uniform film, and then the film is dissolved in ultrapure water to obtain water-soluble all-inorganic perovskite quantum dots.
其中:in:
步骤1)所述的混合溶液Ⅰ中PbX2的浓度为0.4mM~1mM,所述的混合溶液Ⅱ中PbA2的浓度为0.2mM~0.5mM;步骤1)所述的向混合溶液Ⅰ或混合溶液Ⅱ中加入油酸和油胺,是指按照体积比混合溶液Ⅰ或混合溶液Ⅱ:油酸:油胺为10~30:1~6:0.5~0.8将油酸和油胺加入到混合溶液Ⅰ或混合溶液Ⅱ中;步骤1)所述的将前驱体溶液加入甲苯中,甲苯与前驱体溶液的体积比为1~100:1。Step 1) The concentration of PbX in the mixed solution I is 0.4mM~1mM, and the concentration of PbA in the mixed solution II is 0.2mM~0.5mM ; Adding oleic acid and oleylamine to solution II refers to mixing solution I or mixed solution II according to the volume ratio: oleic acid: oleylamine is 10-30: 1-6: 0.5-0.8 and adding oleic acid and oleylamine to the mixed solution In I or mixed solution II; step 1) adding the precursor solution into toluene, the volume ratio of toluene to precursor solution is 1-100:1.
步骤1)所述的将前驱体溶液加入甲苯中是指在温度为10~40℃、搅拌速率为1000rpm~1500rpm的条件下,将前驱体溶液加入甲苯中。Adding the precursor solution to toluene in step 1) refers to adding the precursor solution to toluene at a temperature of 10-40° C. and a stirring rate of 1000 rpm to 1500 rpm.
步骤2)所述的双亲性磷脂氯仿溶液由双亲性磷脂粉末加入氯仿中配制,其浓度为10~20mg/mL。The amphiphilic phospholipid chloroform solution described in step 2) is prepared by adding amphiphilic phospholipid powder into chloroform, and its concentration is 10-20 mg/mL.
步骤2)所述的去除有机溶剂形成均匀薄膜是指在旋转蒸发仪上减压去除有机溶剂。Step 2) the removal of the organic solvent to form a uniform film refers to the removal of the organic solvent under reduced pressure on a rotary evaporator.
步骤2)所述的将薄膜溶解于超纯水中,得到水溶性全无机钙钛矿量子点是指将薄膜溶解于超纯水中后,进一步经离心、再溶解于超纯水中提纯,得到水溶性全无机钙钛矿量子点。Step 2) dissolving the film in ultrapure water to obtain water-soluble all-inorganic perovskite quantum dots refers to dissolving the film in ultrapure water, further centrifuging, and then dissolving in ultrapure water for purification. Water-soluble all-inorganic perovskite quantum dots were obtained.
有益效果:与现有技术相比,本发明具有以下优势:Beneficial effect: compared with the prior art, the present invention has the following advantages:
1)本发明采用磷脂包裹技术,在油溶性全无机钙钛矿量子点表面包覆磷脂膜,提高了全无机钙钛矿量子点的水稳定性,使生物应用成为可能;1) The present invention uses phospholipid encapsulation technology to coat the surface of oil-soluble all-inorganic perovskite quantum dots with a phospholipid film, which improves the water stability of all-inorganic perovskite quantum dots and makes biological applications possible;
2)本发明利用磷脂膜提高了全无机钙钛矿量子点的生物相容性,同时减少了量子点中有毒元素的释放,降低了量子点的生物毒性;2) The present invention improves the biocompatibility of the all-inorganic perovskite quantum dots by utilizing the phospholipid film, reduces the release of toxic elements in the quantum dots, and reduces the biological toxicity of the quantum dots;
3)本发明操作简单,可选择性结构多,可重复性高,为得到水溶性全无机钙钛矿量子点提供了简便高效的方法。3) The invention has simple operation, multiple optional structures and high repeatability, and provides a simple and efficient method for obtaining water-soluble all-inorganic perovskite quantum dots.
附图说明Description of drawings
图1是本发明制备的水溶性全无机CsPbBr3钙钛矿量子点在11d内荧光随时间的变化趋势示意图;Fig. 1 is the water-soluble all-inorganic CsPbBr3 perovskite quantum dot prepared by the present invention schematic diagram of the changing trend of fluorescence with time in 11d;
图2是具有磁性分离能力的水溶性全无机CsPbBr3钙钛矿量子点在11d内荧光随时间的变化趋势示意图。Fig. 2 is a schematic diagram of the change trend of fluorescence with time within 11d of water-soluble all-inorganic CsPbBr 3 perovskite quantum dots with magnetic separation ability.
具体实施方式Detailed ways
本发明采用双亲性磷脂分子作为媒介,使油溶性全无机钙钛矿量子点均匀分散在水中,具备了生物应用的能力,下面结合附图和实施例对本发明作更进一步的说明:The present invention uses amphiphilic phospholipid molecules as a medium, so that the oil-soluble all-inorganic perovskite quantum dots are evenly dispersed in water, and have the ability of biological application. The present invention will be further described below in conjunction with the accompanying drawings and examples:
实施例1:Example 1:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3,外层为双亲性磷脂二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、二棕榈酰磷脂酰胆碱的重量比例为1:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot has a micellar structure, the inner layer is all-inorganic perovskite quantum dot CsPbBr 3 , and the outer layer is amphiphilic phospholipid Dipalmitoylphosphatidylcholine, the inner and outer layers are connected by hydrophilic and hydrophobic interactions, wherein the weight ratio of all-inorganic perovskite quantum dots CsPbBr 3 and dipalmitoylphosphatidylcholine is 1:54, and its preparation Include the following steps:
步骤1:按摩尔比1:1取溴化铅粉末、和溴化铯粉末溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.4mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将0.1mL上述前驱体在30℃大力搅拌下,缓慢加入10mL甲苯中,得到全无机CsPbBr3钙钛矿量子点。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1 and dissolve them in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.4 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine to stabilize , sonicated until the solution was clear to obtain a precursor solution; 0.1 mL of the above precursor was slowly added to 10 mL of toluene under vigorous stirring at 30 ° C to obtain all-inorganic CsPbBr 3 perovskite quantum dots.
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:在100mL单口烧瓶中,将全无机CsPbBr3钙钛矿量子点甲苯溶液和二棕榈酰磷脂酰胆碱氯仿溶液按照1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 3: In a 100mL single-necked flask, fully mix the all-inorganic CsPbBr 3 perovskite quantum dot toluene solution and the dipalmitoylphosphatidylcholine chloroform solution at a ratio of 1:54, and evaporate the organic solvent under reduced pressure to obtain a uniform film.
步骤4:加入去离子水使薄膜全部溶解后,离心,重新分散在水中,得到水溶性全无机钙钛矿量子点。Step 4: After adding deionized water to completely dissolve the film, centrifuge and redisperse in water to obtain water-soluble all-inorganic perovskite quantum dots.
实施例2:Example 2:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr1.5Cl1.5,外层为双亲性磷脂二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr1.5Cl1.5、二棕榈酰磷脂酰胆碱的重量比例为1.35:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot is a micellar structure, the inner layer is an all-inorganic perovskite quantum dot CsPbBr 1.5 Cl 1.5 , and the outer layer is an amphiphilic The phospholipid dipalmitoylphosphatidylcholine is connected by hydrophilic and hydrophobic interactions between the inner and outer layers, and the weight ratio of all-inorganic perovskite quantum dots CsPbBr 1.5 Cl 1.5 to dipalmitoylphosphatidylcholine is 1.35: 54, its preparation comprises the following steps:
步骤1:按照摩尔比为0.5:0.5:1取溴化铅粉末、氯化铅粉末和溴化铯粉末溶解在10mL二甲基亚砜中,其中氯化铅浓度为0.2mM;再加入2mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入10mL甲苯中,得到全无机钙钛矿量子点CsPbBr1.5Cl1.5的甲苯溶液。Step 1: Dissolve lead bromide powder, lead chloride powder and cesium bromide powder in 10 mL of dimethyl sulfoxide according to the molar ratio of 0.5:0.5:1, where the concentration of lead chloride is 0.2 mM; then add 2 mL of oil Acid and 0.5mL oleylamine are stable, sonicate until the solution is clear to obtain a precursor solution; slowly add 1mL of the above precursor to 10mL of toluene under vigorous stirring at 30°C to obtain the toluene of all-inorganic perovskite quantum dots CsPbBr 1.5 Cl 1.5 solution.
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr1.5Cl1.5甲苯溶液和二棕榈酰磷脂酰胆碱氯仿溶液按照1.35:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 3: In a 100mL single-necked flask, fully mix the all-inorganic perovskite quantum dot CsPbBr 1.5 Cl 1.5 toluene solution and the dipalmitoylphosphatidylcholine chloroform solution in a ratio of 1.35:54, and evaporate the organic solvent under reduced pressure to obtain a uniform film.
步骤4:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 4: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例3:Example 3:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr1.5I1.5,外层为双亲性磷脂二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr1.5I1.5、二棕榈酰磷脂酰胆碱的重量比例为1.2:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot is a micellar structure, the inner layer is an all-inorganic perovskite quantum dot CsPbBr 1.5 I 1.5 , and the outer layer is an amphiphilic The phospholipid dipalmitoylphosphatidylcholine is connected by hydrophilic and hydrophobic interactions between the inner and outer layers. The weight ratio of all-inorganic perovskite quantum dots CsPbBr 1.5 I 1.5 to dipalmitoylphosphatidylcholine is 1.2: 54, its preparation comprises the following steps:
步骤1:按照摩尔比为0.5:0.5:1取溴化铅粉末、碘化铅粉末和溴化铯粉末溶解在10mL二甲基亚砜中,其中碘化铅浓度为0.5mM;再加入2mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入10mL甲苯中,得到全无机钙钛矿量子点CsPbBr1.5I1.5的甲苯溶液。Step 1: Dissolve lead bromide powder, lead iodide powder and cesium bromide powder in 10 mL of dimethyl sulfoxide according to the molar ratio of 0.5:0.5:1, where the concentration of lead iodide is 0.5 mM; add 2 mL of oil The acid and 0.5mL oleylamine are stable, and the solution is sonicated until the solution is clear to obtain a precursor solution; 1mL of the above precursor is slowly added to 10mL of toluene under vigorous stirring at 30°C to obtain the toluene of all-inorganic perovskite quantum dots CsPbBr 1.5 I 1.5 solution.
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr1.5I1.5甲苯溶液和二棕榈酰磷脂酰胆碱氯仿溶液按照1.2:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 3: In a 100mL single-necked flask, fully mix the all-inorganic perovskite quantum dot CsPbBr 1.5 I 1.5 toluene solution and the dipalmitoylphosphatidylcholine chloroform solution in a ratio of 1.2:54, and evaporate the organic solvent under reduced pressure to obtain a uniform film.
步骤4:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 4: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例4:Example 4:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3,外层为双亲性大豆磷脂,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、大豆磷脂的重量比例为1:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot has a micellar structure, the inner layer is all-inorganic perovskite quantum dot CsPbBr 3 , and the outer layer is amphiphilic soybean Phospholipids are connected by hydrophilic and hydrophobic interactions between the inner and outer layers, wherein the weight ratio of all-inorganic perovskite quantum dots CsPbBr 3 and soybean phospholipids is 1:54, and its preparation includes the following steps:
步骤1:按摩尔比1:1取溴化铅粉末、和溴化铯粉末溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.6mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入1mL甲苯中,得到全无机CsPbBr3钙钛矿量子点。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1 and dissolve them in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.6 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine to stabilize , sonicated until the solution was clear to obtain a precursor solution; 1 mL of the above precursor was slowly added to 1 mL of toluene under vigorous stirring at 30 ° C to obtain all-inorganic CsPbBr 3 perovskite quantum dots.
步骤2:取大豆磷脂粉末200mg,溶解在20mL氯仿中,得到10mg/mL的大豆磷脂氯仿溶液。Step 2: Take 200 mg of soybean lecithin powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL soybean lecithin chloroform solution.
步骤3:在100mL单口烧瓶中,将全无机CsPbBr3钙钛矿量子点甲苯溶液和大豆磷脂氯仿溶液按照1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 3: In a 100mL single-necked flask, fully mix the all-inorganic CsPbBr 3 perovskite quantum dot toluene solution and the soybean phospholipid chloroform solution at a ratio of 1:54, and evaporate the organic solvent under reduced pressure to obtain a uniform film.
步骤4:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 4: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例5:Example 5:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3,外层为双亲性二硬脂酰基磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、二硬脂酰基磷脂酰胆碱的重量比例为1:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot has a micellar structure, the inner layer is all-inorganic perovskite quantum dot CsPbBr 3 , and the outer layer is amphiphilic bismuth Stearoyl phosphatidylcholine, the inner and outer layers are connected by hydrophilic and hydrophobic interactions, wherein the weight ratio of all-inorganic perovskite quantum dots CsPbBr 3 and distearoylphosphatidylcholine is 1:54, its Preparation includes the following steps:
步骤1:按摩尔比1:1取溴化铅粉末、和溴化铯粉末溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.8mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将0.1mL上述前驱体在30℃大力搅拌下,缓慢加入10mL甲苯中,得到全无机CsPbBr3钙钛矿量子点。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1 and dissolve them in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.8 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine to stabilize , sonicated until the solution was clear to obtain a precursor solution; 0.1 mL of the above precursor was slowly added to 10 mL of toluene under vigorous stirring at 30 ° C to obtain all-inorganic CsPbBr 3 perovskite quantum dots.
步骤2:取二硬脂酰基磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二硬脂酰基磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of distearoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL distearoylphosphatidylcholine chloroform solution.
步骤3:在100mL单口烧瓶中,将全无机CsPbBr3钙钛矿量子点甲苯溶液和二硬脂酰基磷脂酰胆碱氯仿溶液按照1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 3: In a 100mL single-necked flask, fully mix the all-inorganic CsPbBr 3 perovskite quantum dot toluene solution and the distearoylphosphatidylcholine chloroform solution at a ratio of 1:54, and evaporate the organic solvent under reduced pressure to obtain a uniform film .
步骤4:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 4: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例6:Embodiment 6:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3和油溶性四氧化三铁纳米粒子,外层为双亲性二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、油溶性四氧化三铁纳米粒子、二棕榈酰磷脂酰胆碱的重量比例为1:1:54,其制备包括以下步骤:A kind of water-soluble all-inorganic perovskite quantum dot, described water-soluble all-inorganic perovskite quantum dot is micellar structure, and its inner layer is all-inorganic perovskite quantum dot CsPbBr 3 and oil-soluble ferric oxide Nanoparticles, the outer layer is amphiphilic dipalmitoylphosphatidylcholine, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions, including all-inorganic perovskite quantum dots CsPbBr 3 , oil-soluble ferric oxide nanoparticles, The weight ratio of dipalmitoylphosphatidylcholine is 1:1:54, and its preparation comprises the following steps:
步骤1:取溴化铅粉末和溴化铯粉末的摩尔比例为1:1,溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.4mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入1mL甲苯中,得到全无机钙钛矿量子点CsPbBr3的甲苯溶液。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1, dissolve in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.4 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine Stable, sonicate until the solution is clear to obtain a precursor solution; slowly add 1 mL of the above precursor to 1 mL of toluene under vigorous stirring at 30 °C to obtain a toluene solution of all-inorganic perovskite quantum dots CsPbBr 3 .
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:取油溶性四氧化三铁纳米粒子200mg,溶解在20mL氯仿中,得到10mg/mL的油溶性四氧化三铁纳米粒子氯仿溶液。Step 3: Take 200 mg of oil-soluble iron ferric oxide nanoparticles and dissolve them in 20 mL of chloroform to obtain a 10 mg/mL oil-soluble iron ferric oxide nano-particle chloroform solution.
步骤4:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr3:油溶性四氧化三铁纳米粒子氯仿溶液:二棕榈酰磷脂酰胆碱氯仿溶液按照1:1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 4: In a 100mL single-necked flask, fully mix the all-inorganic perovskite quantum dots CsPbBr 3 : oil-soluble iron ferric oxide nanoparticles in chloroform: dipalmitoylphosphatidylcholine in chloroform at a ratio of 1:1:54 , the organic solvent was evaporated under reduced pressure to obtain a uniform film.
步骤5:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 5: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例7:Embodiment 7:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3和油溶性四氧化三铁纳米粒子,外层为双亲性二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、油溶性四氧化三铁纳米粒子、二棕榈酰磷脂酰胆碱的重量比例为1.35:1:54,其制备包括以下步骤:A kind of water-soluble all-inorganic perovskite quantum dot, described water-soluble all-inorganic perovskite quantum dot is micellar structure, and its inner layer is all-inorganic perovskite quantum dot CsPbBr 3 and oil-soluble ferric oxide Nanoparticles, the outer layer is amphiphilic dipalmitoylphosphatidylcholine, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions, including all-inorganic perovskite quantum dots CsPbBr 3 , oil-soluble ferric oxide nanoparticles, The weight ratio of dipalmitoylphosphatidylcholine is 1.35:1:54, and its preparation comprises the following steps:
步骤1:取溴化铅粉末和溴化铯粉末的摩尔比例为1:1,溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.5mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入1mL甲苯中,得到全无机钙钛矿量子点CsPbBr3的甲苯溶液。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1, dissolve in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.5 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine Stable, sonicate until the solution is clear to obtain a precursor solution; slowly add 1 mL of the above precursor to 1 mL of toluene under vigorous stirring at 30 °C to obtain a toluene solution of all-inorganic perovskite quantum dots CsPbBr 3 .
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:取油溶性四氧化三铁纳米粒子200mg,溶解在20mL氯仿中,得到10mg/mL的油溶性四氧化三铁纳米粒子氯仿溶液。Step 3: Take 200 mg of oil-soluble iron ferric oxide nanoparticles and dissolve them in 20 mL of chloroform to obtain a 10 mg/mL oil-soluble iron ferric oxide nano-particle chloroform solution.
步骤4:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr3:油溶性四氧化三铁纳米粒子氯仿溶液:二棕榈酰磷脂酰胆碱氯仿溶液按照1.35:1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 4: In a 100mL single-necked flask, mix the all-inorganic perovskite quantum dots CsPbBr 3 : oil-soluble iron ferric oxide nanoparticles in chloroform: dipalmitoylphosphatidylcholine in chloroform at a ratio of 1.35:1:54 , the organic solvent was evaporated under reduced pressure to obtain a uniform film.
步骤5:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 5: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例8:Embodiment 8:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3和油溶性金纳米粒子,外层为双亲性二棕榈酰磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、油溶性金纳米粒子、二棕榈酰磷脂酰胆碱的重量比例为1:1:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot is a micellar structure, and its inner layer is an all-inorganic perovskite quantum dot CsPbBr 3 and oil-soluble gold nanoparticles, The outer layer is amphiphilic dipalmitoylphosphatidylcholine, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions, in which all-inorganic perovskite quantum dots CsPbBr 3 , oil-soluble gold nanoparticles, The weight ratio of the base is 1:1:54, and its preparation includes the following steps:
步骤1:取溴化铅粉末和溴化铯粉末的摩尔比例为1:1,溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.7mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入1mL甲苯中,得到全无机钙钛矿量子点CsPbBr3的甲苯溶液。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1, dissolve in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.7 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine Stable, sonicate until the solution is clear to obtain a precursor solution; slowly add 1 mL of the above precursor to 1 mL of toluene under vigorous stirring at 30 °C to obtain a toluene solution of all-inorganic perovskite quantum dots CsPbBr 3 .
步骤2:取二棕榈酰磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二棕榈酰磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of dipalmitoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL dipalmitoylphosphatidylcholine chloroform solution.
步骤3:取油溶性金纳米粒子200mg,溶解在20mL氯仿中,得到10mg/mL的油溶性金纳米粒子氯仿溶液。Step 3: Take 200 mg of oil-soluble gold nanoparticles and dissolve them in 20 mL of chloroform to obtain a 10 mg/mL chloroform solution of oil-soluble gold nanoparticles.
步骤4:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr3:油溶性金纳米粒子氯仿溶液:二棕榈酰磷脂酰胆碱氯仿溶液按照1:1:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 4: In a 100mL single-necked flask, fully mix the all-inorganic perovskite quantum dots CsPbBr 3 : oil-soluble gold nanoparticles in chloroform: dipalmitoylphosphatidylcholine in chloroform in a ratio of 1:1:54, and depressurize The organic solvent was evaporated to obtain a uniform film.
步骤5:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 5: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
实施例9:Embodiment 9:
一种水溶性全无机钙钛矿量子点,所述的水溶性全无机钙钛矿量子点为胶束状结构,其内层为全无机钙钛矿量子点CsPbBr3和油溶性金纳米粒子,外层为双亲性二硬脂酰基磷脂酰胆碱,内外层之间通过亲水和疏水相互作用相连接,其中全无机钙钛矿量子点CsPbBr3、油溶性金纳米粒子、二硬脂酰基磷脂酰胆碱的重量比例为1:1.35:54,其制备包括以下步骤:A water-soluble all-inorganic perovskite quantum dot, the water-soluble all-inorganic perovskite quantum dot is a micellar structure, and its inner layer is an all-inorganic perovskite quantum dot CsPbBr 3 and oil-soluble gold nanoparticles, The outer layer is amphiphilic distearoyl phosphatidylcholine, and the inner and outer layers are connected by hydrophilic and hydrophobic interactions, in which all-inorganic perovskite quantum dots CsPbBr 3 , oil-soluble gold nanoparticles, The weight ratio of acetylcholine is 1:1.35:54, and its preparation comprises the following steps:
步骤1:取溴化铅粉末和溴化铯粉末的摩尔比例为1:1,溶解在10mL二甲基亚砜中,其中溴化铅浓度为0.4mM;再加入1mL油酸和0.5mL油胺稳定,超声至溶液澄清,得到前驱体溶液;将1mL上述前驱体在30℃大力搅拌下,缓慢加入1mL甲苯中,得到全无机钙钛矿量子点CsPbBr3的甲苯溶液。Step 1: Take lead bromide powder and cesium bromide powder at a molar ratio of 1:1, dissolve in 10 mL of dimethyl sulfoxide, where the concentration of lead bromide is 0.4 mM; then add 1 mL of oleic acid and 0.5 mL of oleylamine Stable, sonicate until the solution is clear to obtain a precursor solution; slowly add 1 mL of the above precursor to 1 mL of toluene under vigorous stirring at 30 °C to obtain a toluene solution of all-inorganic perovskite quantum dots CsPbBr 3 .
步骤2:取二硬脂酰基磷脂酰胆碱粉末200mg,溶解在20mL氯仿中,得到10mg/mL的二硬脂酰基磷脂酰胆碱氯仿溶液。Step 2: Take 200 mg of distearoylphosphatidylcholine powder and dissolve it in 20 mL of chloroform to obtain a 10 mg/mL distearoylphosphatidylcholine chloroform solution.
步骤3:取油溶性金纳米粒子200mg,溶解在20mL氯仿中,得到10mg/mL的油溶性金纳米粒子氯仿溶液。Step 3: Take 200 mg of oil-soluble gold nanoparticles and dissolve them in 20 mL of chloroform to obtain a 10 mg/mL chloroform solution of oil-soluble gold nanoparticles.
步骤4:在100mL单口烧瓶中,将全无机钙钛矿量子点CsPbBr3:油溶性金纳米粒子氯仿溶液:二硬脂酰基磷脂酰胆碱氯仿溶液按照1:1.35:54的比例充分混合,减压蒸发有机溶剂,得到均匀薄膜。Step 4: In a 100mL single-necked flask, the all-inorganic perovskite quantum dots CsPbBr 3 : oil-soluble gold nanoparticles chloroform solution: distearoylphosphatidylcholine chloroform solution is fully mixed according to the ratio of 1:1.35:54, and the The organic solvent was evaporated under high pressure to obtain a uniform film.
步骤5:加入去离子水使薄膜全部溶解后,离心,重新分散在水中。Step 5: After adding deionized water to dissolve the film completely, centrifuge and redisperse in water.
图1可以看出,通过磷脂包覆的全无机钙钛矿量子点能在水中实现10天以上的荧光发射;图2可以看出,功能化纳米粒子能够简单的被加入到水溶性全无机钙钛矿量子点中,并且具有长时间荧光发射能力。It can be seen from Figure 1 that the all-inorganic perovskite quantum dots coated with phospholipids can achieve fluorescence emission in water for more than 10 days; it can be seen from Figure 2 that functionalized nanoparticles can be simply added to water-soluble all-inorganic calcium Titanium quantum dots, and have long-term fluorescence emission ability.
以上所述仅是本发明的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications are also possible. It should be regarded as the protection scope of the present invention.
Claims (10)
- A kind of 1. water solubility full-inorganic perovskite quantum dot, it is characterised in that:The water-soluble full-inorganic perovskite quantum dot For micelle-like structures, its internal layer is full-inorganic perovskite quantum dot CsPbX3Or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3, X represent Cl, Br or I in one kind, A represent Cl or I in one kind, 0 < n < 1, its outer layer is amphiphilic phosphatide, It is connected between ectonexine by hydrophilic with hydrophobic interaction.
- A kind of 2. water-soluble full-inorganic perovskite quantum dot as claimed in claim 1, it is characterised in that:The water solubility is complete Inorganic perovskite quantum dot is micelle-like structures, its internal layer is full-inorganic perovskite quantum dot CsPbX3And oil-soluble nano particles Or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3And oil-soluble nano particles, X represent one kind in Cl, Br or I, A is represented One kind in Cl or I, 0 < n < 1, its outer layer are amphiphilic phosphatide, are connected between ectonexine by hydrophilic with hydrophobic interaction Connect.
- A kind of 3. water-soluble full-inorganic perovskite quantum dot as claimed in claim 1 or 2, it is characterised in that:The parents Property phosphatide be dipalmitoylphosphatidylcholine, soybean lecithin or distearoyl phosphatidylcholine in one kind.
- A kind of 4. water-soluble full-inorganic perovskite quantum dot as claimed in claim 1, it is characterised in that:The full-inorganic calcium Titanium ore quantum dot CsPbX3Or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3Mixing ratio by weight example with amphiphilic phosphatide is 1 ~1.35:54.
- A kind of 5. water-soluble full-inorganic perovskite quantum dot as claimed in claim 2, it is characterised in that:The full-inorganic calcium Titanium ore quantum dot CsPbX3Or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3With oil-soluble nano particles, amphiphilic phosphatide three The Mixing ratio by weight example of person is 1~1.35:1~1.35:54.
- 6. a kind of preparation method of full-inorganic perovskite quantum dot water-soluble as described in claim 1 or 2, its feature exist In:This method comprises the following steps:1) full-inorganic perovskite quantum dot CsPbX3Or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3Preparation:By molecular formula CsPbX3The molar ratio of middle each element is by PbX2Powder and CsX powder, which are dissolved in dimethyl sulfoxide (DMSO), obtains mixed solution I, or By molecular formula CsPb (BrnA1-n)3The molar ratio of middle each element is by PbBr2Powder, PbA2Powder, CsBr powder and CsA powder are molten Solution obtains mixed solution II in dimethyl sulfoxide (DMSO), backward mixed solution I or mixed solution II in add oleic acid and oleyl amine, surpass Sound to clarification obtains precursor solution, afterwards adds in toluene precursor solution, obtains full-inorganic perovskite quantum dot CsPbX3Toluene solution or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3Toluene solution;2) preparation of water-soluble full-inorganic perovskite quantum dot:In proportion by full-inorganic perovskite quantum dot CsPbX3Toluene it is molten Liquid or full-inorganic perovskite quantum dot CsPb (BrnA1-n)3Toluene solution and amphiphilic phosphatide chloroformic solution, oil solubility nanometer grain Sub- chloroformic solution after mixing, removes organic solvent and forms uniform film, afterwards by Film Fractionation in ultra-pure water, obtain water Dissolubility full-inorganic perovskite quantum dot.
- A kind of 7. preparation method of water-soluble full-inorganic perovskite quantum dot as claimed in claim 6, it is characterised in that:Step 1) PbX in the mixed solution I described in2Concentration be 0.4mM~1mM, PbA in the mixed solution II2Concentration be 0.2mM ~0.5mM;Oleic acid and oleyl amine are added into mixed solution I or mixed solution II described in step 1), refers to mix according to volume ratio Close solution I or mixed solution II:Oleic acid:Oleyl amine is 10~30:1~6:Oleic acid and oleyl amine are added to mixed solution by 0.5~0.8 I or mixed solution II in;Adding precursor solution in toluene described in step 1), the volume ratio of toluene and precursor solution is 1~100:1.
- A kind of 8. preparation method of water-soluble full-inorganic perovskite quantum dot as claimed in claim 6, it is characterised in that:Step 2) the amphiphilic phosphatide chloroformic solution described in is added in chloroform by amphiphilic phosphatide powder to be prepared, its concentration is 10~20mg/mL.
- A kind of 9. preparation method of water-soluble full-inorganic perovskite quantum dot as claimed in claim 6, it is characterised in that:Step 2) the removal organic solvent described in forms uniform film and refers to depressurize removal organic solvent on a rotary evaporator.
- A kind of 10. preparation method of water-soluble full-inorganic perovskite quantum dot as claimed in claim 6, it is characterised in that:Step It is rapid 2) described in by Film Fractionation in ultra-pure water, obtain water-soluble full-inorganic perovskite quantum dot and refer to Film Fractionation in super After in pure water, further through centrifuging, being re-dissolved in purify in ultra-pure water, water-soluble full-inorganic perovskite quantum dot is obtained.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711307716.6A CN108034419B (en) | 2017-12-11 | 2017-12-11 | Water-soluble all-inorganic perovskite quantum dot and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711307716.6A CN108034419B (en) | 2017-12-11 | 2017-12-11 | Water-soluble all-inorganic perovskite quantum dot and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108034419A true CN108034419A (en) | 2018-05-15 |
CN108034419B CN108034419B (en) | 2020-01-03 |
Family
ID=62101684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711307716.6A Active CN108034419B (en) | 2017-12-11 | 2017-12-11 | Water-soluble all-inorganic perovskite quantum dot and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108034419B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107880875A (en) * | 2017-12-11 | 2018-04-06 | 东南大学 | Cell imaging probe based on full-inorganic perovskite quantum dot and preparation method thereof |
CN109852372A (en) * | 2018-12-10 | 2019-06-07 | 吉林大学 | A kind of CsPbBr of phospholipid micelles encapsulation3Nanocrystalline composite material and its application |
CN109913201A (en) * | 2019-04-01 | 2019-06-21 | 苏州大学 | Near-infrared second-region fluorescent nanoprobes based on black phosphorus and their preparation and applications |
CN111378444A (en) * | 2018-12-27 | 2020-07-07 | Tcl集团股份有限公司 | Quantum dot film and preparation method thereof |
CN114295591A (en) * | 2021-12-01 | 2022-04-08 | 无锡市第二人民医院 | Dual-signal nanoprobe and its application in the detection of prostate specific antigen |
CN114525129A (en) * | 2022-01-27 | 2022-05-24 | 闽都创新实验室 | Preparation method and application of mixed halogen perovskite quantum dot |
CN116078427A (en) * | 2023-02-07 | 2023-05-09 | 无锡市第二人民医院 | A kind of nanozyme and the method using it to detect nuclear matrix protein 22 |
CN116144361A (en) * | 2023-02-09 | 2023-05-23 | 平顶山学院 | Lecithin functionalized high-brightness fluorescent nano probe and preparation method thereof |
CN116904192A (en) * | 2023-07-05 | 2023-10-20 | 华中科技大学鄂州工业技术研究院 | Preparation methods and applications of all-inorganic perovskite quantum dots |
CN116904193A (en) * | 2023-07-05 | 2023-10-20 | 华中科技大学鄂州工业技术研究院 | Method for passivating surface defects of all-inorganic perovskite quantum dots and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103565744A (en) * | 2012-07-26 | 2014-02-12 | 上海晟纳实业有限公司 | Macromolecular phosphatidylglycerol nanoliposome, and preparation methods and applications thereof |
CN104388089A (en) * | 2014-11-04 | 2015-03-04 | 北京理工大学 | High-fluorescence-quantum-yield hybridized perovskite quantum dot material and preparation method thereof |
CN105331362A (en) * | 2015-12-07 | 2016-02-17 | 南京理工大学 | High-yield preparing method for inorganic halogen perovskite fluorescent quantum dots at room temperature |
CN105535996A (en) * | 2016-01-08 | 2016-05-04 | 贵州医科大学 | Novel fluorescence lipidosome nano probe and preparing method thereof |
CN105720195A (en) * | 2016-04-21 | 2016-06-29 | 南京理工大学 | Inorganic halogen perovskite resistive random access memory and preparation method |
CN106590626A (en) * | 2016-12-06 | 2017-04-26 | 广东昭信光电科技有限公司 | Cation-doped perovskite type quantum dot and preparation method thereof |
CN107195741A (en) * | 2017-04-06 | 2017-09-22 | 南京理工大学 | A kind of full-inorganic quantum dot backlight LED preparation method |
-
2017
- 2017-12-11 CN CN201711307716.6A patent/CN108034419B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103565744A (en) * | 2012-07-26 | 2014-02-12 | 上海晟纳实业有限公司 | Macromolecular phosphatidylglycerol nanoliposome, and preparation methods and applications thereof |
CN104388089A (en) * | 2014-11-04 | 2015-03-04 | 北京理工大学 | High-fluorescence-quantum-yield hybridized perovskite quantum dot material and preparation method thereof |
CN105331362A (en) * | 2015-12-07 | 2016-02-17 | 南京理工大学 | High-yield preparing method for inorganic halogen perovskite fluorescent quantum dots at room temperature |
CN105535996A (en) * | 2016-01-08 | 2016-05-04 | 贵州医科大学 | Novel fluorescence lipidosome nano probe and preparing method thereof |
CN105720195A (en) * | 2016-04-21 | 2016-06-29 | 南京理工大学 | Inorganic halogen perovskite resistive random access memory and preparation method |
CN106590626A (en) * | 2016-12-06 | 2017-04-26 | 广东昭信光电科技有限公司 | Cation-doped perovskite type quantum dot and preparation method thereof |
CN107195741A (en) * | 2017-04-06 | 2017-09-22 | 南京理工大学 | A kind of full-inorganic quantum dot backlight LED preparation method |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107880875A (en) * | 2017-12-11 | 2018-04-06 | 东南大学 | Cell imaging probe based on full-inorganic perovskite quantum dot and preparation method thereof |
CN107880875B (en) * | 2017-12-11 | 2020-01-07 | 东南大学 | Cell imaging probe based on all-inorganic perovskite quantum dots and preparation method thereof |
CN109852372B (en) * | 2018-12-10 | 2021-10-29 | 吉林大学 | A phospholipid micelle encapsulated CsPbBr3 nanocrystalline composite and its application |
CN109852372A (en) * | 2018-12-10 | 2019-06-07 | 吉林大学 | A kind of CsPbBr of phospholipid micelles encapsulation3Nanocrystalline composite material and its application |
CN111378444A (en) * | 2018-12-27 | 2020-07-07 | Tcl集团股份有限公司 | Quantum dot film and preparation method thereof |
CN109913201B (en) * | 2019-04-01 | 2022-03-01 | 苏州大学 | Near-infrared two-region fluorescent nano probe based on black phosphorus and preparation and application thereof |
CN109913201A (en) * | 2019-04-01 | 2019-06-21 | 苏州大学 | Near-infrared second-region fluorescent nanoprobes based on black phosphorus and their preparation and applications |
CN114295591A (en) * | 2021-12-01 | 2022-04-08 | 无锡市第二人民医院 | Dual-signal nanoprobe and its application in the detection of prostate specific antigen |
CN114525129A (en) * | 2022-01-27 | 2022-05-24 | 闽都创新实验室 | Preparation method and application of mixed halogen perovskite quantum dot |
CN114525129B (en) * | 2022-01-27 | 2023-10-03 | 闽都创新实验室 | Preparation method and application of mixed halogen perovskite quantum dot |
CN116078427A (en) * | 2023-02-07 | 2023-05-09 | 无锡市第二人民医院 | A kind of nanozyme and the method using it to detect nuclear matrix protein 22 |
CN116144361A (en) * | 2023-02-09 | 2023-05-23 | 平顶山学院 | Lecithin functionalized high-brightness fluorescent nano probe and preparation method thereof |
CN116144361B (en) * | 2023-02-09 | 2024-06-07 | 平顶山学院 | Lecithin functionalized high brightness fluorescent nanoprobe and preparation method thereof |
CN116904192A (en) * | 2023-07-05 | 2023-10-20 | 华中科技大学鄂州工业技术研究院 | Preparation methods and applications of all-inorganic perovskite quantum dots |
CN116904193A (en) * | 2023-07-05 | 2023-10-20 | 华中科技大学鄂州工业技术研究院 | Method for passivating surface defects of all-inorganic perovskite quantum dots and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108034419B (en) | 2020-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108034419A (en) | A kind of water solubility full-inorganic perovskite quantum dot and preparation method thereof | |
CN107880875B (en) | Cell imaging probe based on all-inorganic perovskite quantum dots and preparation method thereof | |
Kim et al. | Multicomponent nanoparticles via self-assembly with cross-linked block copolymer surfactants | |
Zhang et al. | ZnO@ silica core–shell nanoparticles with remarkable luminescence and stability in cell imaging | |
CN103189306B (en) | There is synthesis and the application thereof of zwitterionic nano particle surface modifying molecular sieve | |
Shehzad et al. | Magnetic surfactants: A review of recent progress in synthesis and applications | |
Chang et al. | Synthesis and properties of magnetic and luminescent Fe3O4/SiO2/Dye/SiO2 nanoparticles | |
Hu et al. | Organic-inorganic nanocomposites synthesized via miniemulsion polymerization | |
JP2008501509A (en) | Non-aggregating core / shell nanocomposite particles | |
JP2006137875A (en) | Semiconductor nanoparticles with high luminescent properties | |
JP2009520102A (en) | Multilayer chromonic structure | |
Chiang et al. | Construction of emission-tunable nanoparticles based on a TICT-AIEgen: Impact of aggregation-induced emission versus twisted intramolecular charge transfer | |
Liang et al. | Decoration of up-converting NaYF 4: Yb, Er (Tm) nanoparticles with surfactant bilayer. A versatile strategy to perform oil-to-water phase transfer and subsequently surface silication | |
Vaishnav et al. | Surfactant-induced self-assembly of CdTe quantum dots into multicolor luminescent hybrid vesicles | |
Li et al. | Chitosan and carboxymethyl cellulose-multilayered magnetic fluorescent systems for reversible protein immobilization | |
Chang et al. | Silica nanoparticles | |
CN111788279B (en) | Method for producing luminescent particle, and biological imaging material | |
KR102143276B1 (en) | Control of hydrophilic and hydrophobic properties using fluorescent nano/Metal particles | |
Fu et al. | Facile synthesis of a highly luminescent carbon dot@ silica nanorattle for in vivo bioimaging | |
JP4270500B2 (en) | Method for producing nanocrystal phosphor | |
Chen et al. | Geometrical confinement of quantum dots in porous nanobeads with ultraefficient fluorescence for cell-specific targeting and bioimaging | |
JP4858775B2 (en) | Method for producing hollow nanoparticles using liposome as template | |
Li et al. | Self-limiting self-assembly of supraparticles for potential biological applications | |
Wu et al. | A general and facile approach to disperse hydrophobic nanocrystals in water with enhanced long-term stability | |
Zhang et al. | Magnetic colloidosomes fabricated by Fe3O4–SiO2 hetero-nanorods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |